Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Chenghui Shuangda Pharmaceutical is a leading Chinese manufacturer of active pharmaceutical ingredients (APIs) and advanced intermediates with cGMP-compliant production recognized by multiple international certifications including CEP (EDQM) and US-DMF. The company is recognized for its high-quality API production (e.g., articaine hydrochloride for local anesthesia) exported globally, especially working in local anesthesia, antiviral, cardiovascular/cerebrovascular, antitumor, digestive, and diabetes areas. It operates as a major CDMO/CRO partner for pharma clients worldwide[1][2][3][5][9].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Chenghui Shuangda Pharmaceutical.